Funeral insurance after cancer

Why cancer history matters at application

Cancer is the second-largest cause of death in New Zealand after cardiovascular disease. The Ministry of Health cancer page tracks incidence, mortality, and 5-year-survival statistics that drive insurer underwriting decisions. For medically-underwritten funeral wordings, cancer history is the most common reason for permanent decline or long postponement on otherwise-eligible applicants.

That doesn't mean cover is unavailable. Guaranteed-acceptance funeral products — which ask no medical questions — work specifically for applicants whose medical history (cancer in particular) makes the medically-underwritten path difficult. The trade-off is the non-accidental-death waiting period: typically 2-3 years from policy start. Surviving the waiting period is the actuarial bet the insurer prices.

What insurers typically ask

• Type of cancer. Different cancer types are underwritten differently. Non-melanoma skin cancers (basal cell, squamous cell) are often treated as immaterial. Most other cancers are rated by stage, treatment, and remission duration. Some cancers (specifically aggressive types like pancreatic, late-stage lung, brain) may be permanent decline on medically-underwritten products regardless of remission.
• Staging at diagnosis. Stage I (localised) is underwritten very differently from Stage IV (metastatic). The TNM staging from your oncology report is the key data point.
• Treatment received. Surgery only, surgery + radiation, surgery + chemotherapy, palliative-intent treatment. Curative-intent completed treatment with no evidence of disease (NED) is the strongest underwriting profile.
• Remission / NED duration. Most NZ medically-underwritten wordings require a defined period of "no evidence of disease" before standard-terms cover — commonly 5 years for early-stage cancers, longer (or permanent decline) for later stages. The clock typically starts from end of treatment, not from diagnosis.
• Recurrence history. Any recurrence resets the remission clock and typically tightens underwriting. Multiple recurrences may be permanent decline on medically-underwritten products.
• Current surveillance. Ongoing oncology follow-up scans, blood markers, mammograms, colonoscopies — these are confirmatory evidence of cancer history. Non-disclosure of cancer history that the insurer can verify via specialist visits in ACC / public-health records is a high-risk path for the policy.
• Family history of cancer. Some wordings ask about first-degree- relative cancer history. Material on genetically-driven cancers (BRCA-linked breast cancer, hereditary colorectal). Less material on most others.

Why guaranteed-acceptance is often the practical answer

For an applicant in remission whose medically-underwritten options are limited (or permanent decline), guaranteed-acceptance funeral cover is typically the practical path. The insurer prices the policy at a standard rate, accepts every applicant, and relies on the 2-3 year non-accidental-death waiting period to manage the risk.

For an applicant in active treatment or recently diagnosed, the same logic applies — but the actuarial trade-off is tighter. Read the waiting-period clause carefully: if death from natural causes occurs within the waiting period, the typical pay-out is a return of premiums plus an accidental-death component, not the full sum-insured. For an applicant with a clear "in remission, expected to survive 2+ years" prognosis, guaranteed-acceptance works. For an applicant with active aggressive disease, the waiting period may dominate the value calculation.

The underwriting topic page documents each NZ insurer's verbatim approach to medical questions vs guaranteed-acceptance where the wording is on file. The waiting-period topic page documents each insurer's non-accidental-death waiting period verbatim.

What to consider as a cancer-history buyer

• Disclose accurately — always. Cancer history is recorded in GP files, DHB / Te Whatu Ora records, pharmaceutical claims (oncology drugs), and ACC sensitive- claims data. The insurer can request a GP report at claim time. Non-disclosed cancer history is one of the most clear-cut reasons for voided policies in NZ funeral-insurance disputes — IFSO Scheme case studies document the pattern.
• Quote both paths. Get a medically-underwritten quote AND a guaranteed-acceptance quote. For early-stage cancer with 5+ years NED, the medically- underwritten loaded premium may be cheaper than guaranteed-acceptance. For later stages or shorter remission, guaranteed-acceptance is typically the only path.
• Time the application. If you're in a postponement window, applying mid-window wastes the application fee and may flag the file negatively if reapplying. Wait until the window closes or apply via guaranteed-acceptance instead.
• Pre-paid funeral plans. A pre-paid funeral plan with a local NZ funeral director is a non-insurance alternative — funds held in trust by the funeral director, no insurer underwriting, no waiting period. Funeral Directors Association of NZ lists member funeral directors. Different product class to insurance.
• WINZ funeral grant. If all insurance and pre-paid options fall through and the estate cannot meet funeral costs, the WINZ funeral grant is the safety-net. Means-tested, capped, not available where adequate insurance exists.

Related guides

• Underwriting — guaranteed acceptance vs medicals
• Waiting period rules
• Funeral insurance for diabetics
• Funeral insurance with a heart condition
• Funeral insurance for smokers
• Funeral insurance for over 65s